Merck's VAXNEUVANCE Archives

PCV14 may be administered to infants 6, 10, and 14 weeks of age in 3 doses

DCGI clears Biological E’s 14-valent pneumococcal conjugate vaccine

PGurus Newsdesk - December 17, 2022 0

Drugs regulator approves BE-PCV14 vaccine to protect infants against Streptococcus pneumoniae infection Biological E. Limited (BE), a Hyderabad-based Pharmaceutical and Vaccine Company Friday announced that...

Tag: Merck’s VAXNEUVANCE

DCGI clears Biological E’s 14-valent pneumococcal conjugate vaccine

BOOKS

Prof Hari Om’s new book “Buddhists Playing With Fire” hits the...

Review of “The Manthan Code” (author Shambhu Sundriyal)

‘I Have the Streets’ – R Ashwin & Sidharth Monga

K Parasaran Miscellany: A book that needs to be read by...

Author Shantanu Gupta’s book on CM Yogi Adityanath creates history with...